Prospect Venture Partners

VC · Palo Alto (United States)

VC

Seed

Series A

Healthcare

Lead investor

Sign up free to access full profile and submit your pitch.

About

Prospect Venture Partners is a venture capital firm specializing in investments at all stages, from seed to growth, including incubation to new companies, first and second round of financing, and expansion capital to later stage private and public companies. It seeks to invest in companies in the life sciences industry including biopharmaceutical and medical device companies. The firm seeks to invest in North America. It typically invests between $500,000 and $10 million of equity in the first round of investment with a total investment between $10 million and $20 million in each of its portfolio company. The firm syndicates its deals as lead or co-lead investor and prefers a board-seat representation. Prospect Venture Partners was founded in 1997 and is based in Palo Alto, California.

Investment Criteria

Other investors that have backed the same portfolio companies as Prospect Venture Partners. Expand any entry to see the shared portfolio companies.

• New Enterprise Associates

  3 shared

  Shared portfolio companies

  • Amicus Therapeutics, Inc.
  • Infinity Pharmaceuticals, Inc.
  • Vitae Pharmaceuticals, Inc.
• Alta Partners LP

  2 shared

  Shared portfolio companies

  • Azelon Pharmaceuticals, Inc.
  • Triple Point Medical, Inc.
• Novo Holdings

  2 shared

  Shared portfolio companies

  • Nora Therapeutics, Inc.
  • Panmira Pharmaceuticals, LLC
• Third Rock Ventures

  2 shared

  Shared portfolio companies

  • NinePoint Medical, Inc.
  • Tinea Pharmaceuticals, Inc.
• Advent Life Sciences

  1 shared

  Shared portfolio companies

  • Infinity Pharmaceuticals, Inc.
• Avalon Ventures

  1 shared

  Shared portfolio companies

  • Panmira Pharmaceuticals, LLC
• BDC Capital

  1 shared

  Shared portfolio companies

  • Azelon Pharmaceuticals, Inc.
• Frazier Healthcare Partners

  1 shared

  Shared portfolio companies

  • Azelon Pharmaceuticals, Inc.
• Frontier Venture Capital

  1 shared

  Shared portfolio companies

  • Chimeros Inc.
• Genesys Capital Partners Inc.

  1 shared

  Shared portfolio companies

  • Azelon Pharmaceuticals, Inc.